Multiple System Atrophy Clinical Trial Roundup

During the MSA Coalition's Clinical Trial Roundup, our partners at Alterity Therapeutics and Theravance Biopharma present on their clinical trials, their work in the Multiple System Atrophy field, and their future research plans. Representatives from both companies attended to answer questions.

We were also joined by Daniel Claassen, MD MS of Vanderbilt University Medical Center who addressed questions on the clinical trial process overall.

A Clinical Trial Frequently Asked Questions Guide sponsored by Takeda Pharmaceuticals is available for download on our website.

THIS EDUCATIONAL SESSION IS NOT INTENDED FOR THE PURPOSE OF PROVIDING MEDICAL ADVICE. All information, content, and material is for informational purposes only and are not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. The information supplied through webinars or on our webpage, or by any representative or agent of the MSA Coalition, whether by telephone, email, letter, or other form of communication, is for informational purposes only and does not constitute medical, legal or other professional advice.